T

he research is as important as it is fraught: scientists at the University of Utah have forged a new partnership with the pharmaceutical giant Janssen to search for biomarkers associated with an increased risk of suicide.

The project, unveiled Friday, seeks to advance existing genetic research on suicide by potentially developing new medications that could help prevent patients from ending their lives.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Reply to Jones Alester Cancel reply

Please enter your name.
Please enter a comment.

Sign up for our Biotech newsletter — The Readout

Your daily guide to what’s new in biotech.